Single-dose Study in Two Panels of Healthy Adult Participants to Assess Immediate-Release and Dispersible Formulations of Pretomanid
Clinical trial NCT04309656 · COMPLETED
Trial details
- NCT number
- NCT04309656
- Sponsor
- Global Alliance for TB Drug Development
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-14
- Primary completion
- 2020-02-28
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.